Marvel Biosciences Corp Stock Price To Earning
MRVL Stock | 0.17 0.01 5.56% |
Marvel Biosciences Corp fundamentals help investors to digest information that contributes to Marvel Biosciences' financial success or failures. It also enables traders to predict the movement of Marvel Stock. The fundamental analysis module provides a way to measure Marvel Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Marvel Biosciences stock.
Marvel | Price To Earning |
Marvel Biosciences Corp Company Price To Earning Analysis
Marvel Biosciences' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Marvel Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Marvel Biosciences is extremely important. It helps to project a fair market value of Marvel Stock properly, considering its historical fundamentals such as Price To Earning. Since Marvel Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Marvel Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Marvel Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Marvel Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Marvel Biosciences Corp has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all Canada stocks is 100.0% higher than that of the company.
Marvel Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Marvel Biosciences from analyzing Marvel Biosciences' financial statements. These drivers represent accounts that assess Marvel Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Marvel Biosciences' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 2.9M | 4.2M | 2.8M | 3.2M | 2.9M | 2.3M | |
Enterprise Value | 2.6M | 1.9M | 2.2M | 3.6M | 3.3M | 1.8M |
Marvel Fundamentals
Return On Equity | -3.8 | ||||
Return On Asset | -1.54 | ||||
Current Valuation | 8.67 M | ||||
Shares Outstanding | 44.79 M | ||||
Shares Owned By Insiders | 26.66 % | ||||
Number Of Shares Shorted | 18 | ||||
Price To Book | 226.82 X | ||||
EBITDA | (2.19 M) | ||||
Net Income | (2.29 M) | ||||
Total Debt | 2.39 M | ||||
Book Value Per Share | (0.07) X | ||||
Cash Flow From Operations | (1.33 M) | ||||
Earnings Per Share | (0.06) X | ||||
Beta | 0.48 | ||||
Market Capitalization | 7.39 M | ||||
Total Asset | 672.39 K | ||||
Retained Earnings | (9.05 M) | ||||
Working Capital | (720.09 K) | ||||
Net Asset | 672.39 K |
About Marvel Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Marvel Biosciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Marvel Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Marvel Biosciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.